Notify me when Tactic Pharma LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | Common Stock, $0.001 par value | 7.5% | $18,253,536 | 506,199 | Robinson Chandler | 24 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|